Novartis Investigative Site

North Bay, Ontario P1B 3Z7

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Chronic Plaque-type Psoriasis, Moderate to Severe Plaque-type Psoriasis, Type 2 Diabetes Mellitus

Studies at this site

• First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks — Completed
• A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early